Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in the British Journal of Cancer ...
The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. AXS-07 is an oral agent that consist ...
The agency stressed that tampons are tested for safety and effectiveness before making it to store shelves, but added that its review of existing data and its own laboratory study should clear up ...